Immunology and Microbiology
Adipokine
30%
Bacteriolysis
10%
CD8
30%
Cell Function
30%
Child Health
30%
Citrobacter Rodentium
100%
Colitis
15%
Colon
30%
Complement
30%
Complement Component C1q
30%
Complement Membrane Attack Complex
10%
Dendritic Cell
8%
Enteritis
30%
Enterohemorrhagic Escherichia Coli
14%
Enteropathogenic Escherichia Coli
14%
Escherichia coli
30%
Exosome
30%
HBsAg
63%
Hepatitis B
84%
Hepatitis B Antigen
63%
Hepatitis B Virus
66%
Homeobox
30%
Human Pathogen
11%
Immune Response
46%
Immunocompromised Patient
11%
Immunotherapy
19%
Infectious Agent
75%
interferon
14%
Interleukin 22
16%
Intestine Flora
60%
Knockout Mouse
16%
Macrophage
44%
Memory T Cell
35%
Microflora
24%
Monospecific Antibody
10%
Mouse
66%
Natural Killer Cell
30%
Polyinosinic:polycytidylic Acid
30%
Progeny
30%
RIG-I
30%
STAT1
30%
T Cell
60%
Tight Junction
30%
Tumor Necrosis Factor
41%
Tumor-Associated Macrophage
30%
Type Three Secretion System
16%
Upregulation
30%
Vaccine Adjuvant
30%
Vaccine Efficacy
33%
Wild Type
13%
Keyphrases
Adipokines
30%
Anticancer
15%
Anticancer Drugs
15%
Bacterial Genotoxins
30%
Bacterial Pathogens
30%
C1q/TNF-related protein-3
30%
Camptothecin
15%
Checkpoint Inhibitors
30%
Chemoimmunotherapy
30%
Citrobacter Rodentium
30%
Clinical Benefit
15%
Depot
15%
EspF
15%
Exosomal
30%
Exosomes
21%
Gut Microbiota
30%
Hepatocellular Carcinoma
30%
Homeobox Containing 1
30%
Immune Activation
15%
Immune-related Adverse Events
15%
In Situ Formation
15%
Infiltration
30%
Influenza Neuraminidase Inhibitor
30%
Intestinal Inflammation
30%
Knock-in Mouse Model
15%
M2 Macrophages
30%
MiR-146a
30%
MiR-146a-5p
30%
Natural Killer Cell Activity
30%
Negatively Regulate
30%
NF-B
34%
Oseltamivir Derivatives
30%
PD-1 Blockade
30%
Proline Derivatives
30%
Promising Strategies
15%
RIG-G
30%
Sal-like Protein 4
30%
Sirtuin 1 (SIRT1)
30%
STAT1 Signaling
30%
Supramolecular Hydrogel
30%
Sustained Release
15%
T Cell Exhaustion
30%
T Cells
39%
Tumor
30%
Tumor Recurrence
15%
Tumor Regression
15%
Tumor Sensitization
30%
Tumor-associated
30%
UshA
30%
Virulence
30%
Pharmacology, Toxicology and Pharmaceutical Science
4 Acetamido 5 Amino 3 (1 Ethylpropoxy) 1 Cyclohexene 1 Carboxylic Acid
20%
Adverse Event
17%
Anticarcinogen
7%
Bacterial Infection
6%
Binding Site
10%
Camptothecin
48%
Carcinogenesis
30%
Chitosan
30%
Citrobacter Rodentium
12%
Colon Cancer
6%
Colon Tumor
6%
Enterohemorrhagic Escherichia Coli
6%
Enteropathogenic Escherichia Coli
6%
Hepatitis B
30%
Hepatitis B Antigen
30%
Hydroxyproline
6%
IC50
10%
Immunosuppressive Agent
8%
Immunotherapy
45%
Infection
28%
Infectious Agent
18%
Inflammation
6%
Influenza A (H5N1)
30%
Influenza A Virus (H5N1)
30%
Interferon
30%
Malignant Neoplasm
44%
Metastasis
10%
Metastasis Potential
7%
Mouse
27%
Nanogel
30%
Neoplasm
71%
Oseltamivir
30%
Pathogenesis
6%
Peramivir
6%
Prodrug
30%
Programmed Death 1 Receptor
20%
Proline
30%
Proline Derivative
30%
Sialidase
30%
Sialidase Inhibitor
50%
Sustained Release
7%
Systemic Administration
7%
Tavokinogene Telseplasmid
23%
Therapeutic Effect
7%
Tumor Microenvironment
22%
Tumor Recurrence
22%
Tumor Regression
22%
